# [Single Cell Multiome ATAC + Gene Expression](https://www.10xgenomics.com/support/single-cell-multiome-atac-plus-gene-expression)
# Workflow
# Pre-processing
## Pipelines
### Cell Ranger
#### [Cell Ranger ARC](https://support.10xgenomics.com/single-cell-multiome-atac-gex/software/overview/welcome)

Can I analyze only the ATAC data from my single cell multiome experiment? [Yes](https://kb.10xgenomics.com/hc/en-us/articles/360061165691-Can-I-analyze-only-the-ATAC-data-from-my-single-cell-multiome-experiment-)

#### [`cellranger-atac count`](https://support.10xgenomics.com/single-cell-atac/software/pipelines/latest/using/count)
[scatacseq.sh](https://github.com/uninchan/barbierilab/blob/main/scMultiome/scatacseq.sh)

#### Understanding Outputs
[Web Summary](https://support.10xgenomics.com/single-cell-atac/software/pipelines/latest/output/summary) (`cellranger-atac count`)

# Downstream analysis


# Literatures
Taavitsainen, S. et al. Single-cell ATAC and RNA sequencing reveal pre-existing and persistent cells associated with prostate cancer relapse. Nat Commun 12, 5307 (2021). [https://doi.org/10.1038/s41467-021-25624-1](https://doi.org/10.1038/s41467-021-25624-1)

Zhang, Z. et al. Loss of CHD1 Promotes Heterogeneous Mechanisms of Resistance to AR-Targeted Therapy via Chromatin Dysregulation. Cancer Cell 37, 584â€“598 (2020). [https://doi.org/10.1016/j.ccell.2020.03.001](https://doi.org/10.1016/j.ccell.2020.03.001)

Qiu, X. et al. MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets. Nat Commun 13, 2559 (2022). [https://doi.org/10.1038/s41467-022-30257-z](https://doi.org/10.1038/s41467-022-30257-z)
